via OTC PR WIRE--Tree of Knowledge International Corp.
(CSE:TOKI; OTC:TRKWF) (the
“
Company” or “
TOK”) announced
today that, in celebration of the 2018 Farm Bill being signed and
Hemp being removed from the US DEA’s Schedule 1 status for the most
harmful substances, it is offering a discount code for products
featured on the Company’s product website (evrcbd.com) and use code
‘2019’ at checkout for 20% off through January. The Company also
announced its outlook for 2019 and has provided an overview of its
activities to date.
TOK is a publicly traded, North American
cannabis healthcare platform led by physicians, focused on
formulated product development and distribution, and backed by
cannabis research and education. With its head office in Toronto
and operations in North York, Ontario and Spokane, Washington, TOK
currently has three primary business segments.
- Multidisciplinary specialty pain clinics with a focus on the
treatment of chronic pain, including controlled applications of
medical cannabis in Canada,
- Development of formulated products for therapeutic purposes and
natural health product alternatives at its manufacturing facility
in Spokane, which provides formulations for the Company’s products
and for third parties equivalent to GMP standards, and
- Distribution and sale of products in the United States, Canada,
Europe, Brazil and China.
Management believes TOK’s primary competitive
advantage is derived from its access to patients and broad
distribution network across North America and international
markets. TOK has one of the largest patient populations in North
America through its strategic relationships with physicians in the
United States and Jack Nathan Health clinics (both in Canada and
internationally), among others. TOK has the ability to conduct
large scale observational studies and clinical trials on various
cannabinoids, generating statistically significant data used for
product development which, in turn, can be monetized through the
Company’s patient and consumer base.
OUTLOOK FOR 2019
Marked as genuinely historic for the cannabis
industry, the passing of the 2018 Farm Bill has removed all
confusion associated with “industrial hemp”. While the Company has
always utilized organically sourced US Dept. of Agriculture
approved industrial hemp in its products, “hemp”, defined as “the
plant Cannabis sativa L. and any part of that plant, including the
seeds thereof and all derivatives, extracts, cannabinoids, isomers,
acids, salts, and salts of isomers, whether growing or not, with a
delta-9 tetrahydrocannabinol concentration of not more than 0.3
percent on a dry weight basis,” has now been officially removed
from the Controlled Substances Act in the United States. While the
Company is still assessing the various implications of the new law,
the development is extremely positive for the Company and its
future development plans in the U.S. and elsewhere.
The year 2018 proved to be a wild ride for the
Cannabis Industry. The year began with unprecedented valuations and
record capital raised for the industry, only in
December to face the worst month for public markets since 1931.
Management believes that despite the challenging and volatile
markets, with the passage of the Farm Bill, demand for cannabis
products will continue to expand and will outstrip current
estimates, however, the market will demand trustworthy, research
based products. The U.S. hemp market is currently estimated at
roughly $800 million, the lion’s share of which is made up of
CBD-based products. With the passage of the Farm Bill, some
forecast that the market could increase to $20 billion by 2022.
(CNBC, “Hemp legalization included in new farm bill could ‘open the
floodgates’ on nascent industry” December 7,
2018).
GOALS FOR 2019:
- The Company is currently working with several strategic
partners and investors and the new Board will be meeting early in
the New Year to develop a financing strategy for the remainder of
year. Ultimately, the Company’s goal is to fund all future
operations and development through the sale of its products and
services.
- The Company intends to differentiate the TOK brands to create a
globally recognized company and develop a business to consumer
model, utilizing the depth of its senior management team’s
connections and experience.
- The Company has made multiple research and development
agreements with major Universities in Canada. New formulations and
targeted delivery methods are the focus of research and development
in the coming year.
- The Company is working to expand its doctor networks and
intends to pursue opportunities with several large retailers
throughout the U.S., South America and the United Kingdom. The
Company is also working on building a sales team in the U.S. and
finalizing its international distribution deals. A key part of the
Company’s immediate strategy is to educate doctors and patients in
the Canadian market on the benefits of TOKI’s CBD products.
- The Company intends to expand its proprietary medical cannabis
best practices education and research program to include all 72
existing Jack Nathan Health clinics in 6 Canadian provinces. The
Company intends to open a new multi-disciplinary pain clinic in the
first quarter of 2019, at the new Jack Nathan Health clinic located
in Vaughan, Ontario.
- The Company intends to optimize its equipment utilization at
its Spokane manufacturing facilities and expand its manufacturing
capacity to keep up with predicted demand.
Jean-Paul Gaillard, CEO commented: “We are now
at a point where we can refine and execute on our strategy to
create globally recognized brands grounded on our physician-led
cannabis health care platform. We are truly excited to capitalize
on our opportunities in 2019.”
YEAR TO DATE
Since becoming listed on July 9, 2018, TOK has
achieved the following:
- Completed the acquisition and merger with Asterion Bio Med Inc.
on December 19, 2018. Management believes that this single
transaction has solidified the Company’s future as a platform for
the aggregation of best-in-class partners to build a global
biomedical company, scientifically focussed with proprietary
formulations, and multiple innovative delivery technologies.
The Company has access to 72 Jack Nathan Health clinics in six
provinces across Canada for its education and research platform,
with over 1.5 million patient visits annually.
- Raised $2.7 million in connection with the acquisition of
Asterion Bio Med Inc.
- Developed world class products, of which its CBD air metered
dosing pens and capsules are approved for the treatment of autism,
Parkinson’s disease and treatment resistant epilepsy by the
Government of Brazil for prescription by physicians. Current
distribution capability exists in the United States, Brazil, the
United Kingdom and China. Product lines have been submitted
in 3 other countries, including Italy, for approval, expected by
the end of Q1 2019.
- Retained renowned seasoned executive Jean-Paul Gaillard (former
architect and leader of Nespresso and Marlboro Classics) to
spearhead corporate growth. Also established a world class
Advisory Board, staffed by industry-leaders.
- Empowered consumers with QR code access on smart phones so that
customers can review third party lab results for the products they
purchase.
- Received certifications from the Food Safety Authority of
Ireland (FSAI) and is currently developing distribution channels
for countries in Europe that will accept FSAI certifications and
labelling through its subsidiary that meets all governmental
standards to do business in the European Union.
- Established fulfillment centre for its production in the United
Kingdom.
- Established a joint venture for future manufacturing at a
facility in Macedonia.
About Jack Nathan Health®
Jack Nathan Health® is a privately owned and
operated Canadian company that is dedicated to improving access to
health care by partnering with highly qualified medical staff and
delivering consistent, easy-access, patient-centric quality care in
state-of-the-art medical and dental clinics within local
communities where people live. A proud partner of Walmart Canada,
Jack Nathan Health® medical and dental clinics are conveniently
located inside Walmart Supercentres across Canada. Clinics are
independently owned and operated and not affiliated with Walmart.
Jack Nathan Health® is a registered trade-mark of Jack Nathan
Medical, Inc. All representations contained herein are made solely
by Jack Nathan Health® and are not independently verified by
Walmart. All Walmart trademarks are the property of Wal-Mart
Stores, Inc. and are used under license. For more information,
virtual clinic tours, and social media links, visit
www.jacknathanhealth.com.
ABOUT TREE OF KNOWLEDGE
The Company produces and sells hemp-based
cannabidiol (“CBD”) products in certain
jurisdictions in the United States, as well as in Europe, Brazil
and China. The Company operates multidisciplinary pain
clinics through its subsidiary Asterion Bio Med Inc. under the
banner; Toronto Poly Clinic (collectively, “TPC”).
Through an exclusive strategic alliance agreement with Jack Nathan
Medical Inc., which operates over 72 Jack Nathan Health medical and
dental clinics in six provinces across Canada, Asterion Bio Med has
access to one of the largest healthcare systems across Canada for
its education and research platform, with over 1.5 million patient
visits annually. TPC is a healthcare leader in the ethical and
controlled use of medical cannabis, managing over 4,800 cannabis
patients. TPC has refined its collective knowledge and focused on
the creation of the MCERP (Medical Cannabis Education, Research and
Best Practice Platform) and MCORP (Medical Cannabis Opioid
Reduction Program). Currently TPC has research agreements with
multiple universities for medical cannabis research and new medical
grade products development. TOK’s CBD product line contains EVR
Premium Hemp Oil, which is an organically grown and handled,
gluten-free, vegan, non-GMO, synergistic compound that is derived
from U.S. Department of Agriculture (USDA) approved industrial hemp
grown in the United States. TOK currently offers several CBD
products, which may be used in connection with the treatment of a
number of ailments and for general wellness purposes.
For further information about TOK, please
contact the following:
Tree of Knowledge International Corp.
Michael Caridi Tel: +1 (917)
295-1374michael@tok.ca
www.tok.ca
THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT
RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.
Forward Looking StatementsThis
news release contains forward-looking statements relating to the
future operations of TOK as combined with Asterion and other
statements that are not historical facts. Forward-looking
statements are often identified by terms such as “will”, “may”,
“should”, “anticipate”, “expects” and similar
expressions. All statements other than statements of historical
fact, included in this release, including, without limitation,
statements regarding the company and the future plans and
objectives of TOK, are forward looking statements that involve
risks and uncertainties. There can be no assurance that such
statements will prove to be accurate and actual results and future
events could differ materially from those anticipated in such
statements. Important factors that could cause actual results to
differ materially from TOK's expectations are risks detailed from
time to time in the filings made by TOK with securities
regulations.
The reader is cautioned that assumptions used in
the preparation of any forward-looking information may prove to be
incorrect. Events or circumstances may cause actual results
to differ materially from those predicted, as a result of numerous
known and unknown risks, uncertainties, and other factors, many of
which are beyond the control of TOK. As a result, TOK cannot
guarantee that the Offer will be completed and that any
forward-looking statement will materialize and the reader is
cautioned not to place undue reliance on any forward-looking
information. Such information, although considered reasonable
by management at the time of preparation, may prove to be incorrect
and actual results may differ materially from those
anticipated. Forward-looking statements contained in this
news release are expressly qualified by this cautionary
statement. The forward-looking statements contained in this
news release are made as of the date of this news release and TOK
will update or revise publicly any of the included forward-looking
statements as expressly required by Canadian securities law.
Tree of Knowledge (CSE:TOKI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tree of Knowledge (CSE:TOKI)
Historical Stock Chart
From Sep 2023 to Sep 2024